Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Kim

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
AIDS and Behavior|July 30, 2013
Unmet HIV service needs among Black men who have sex with men in the United StatesDavid R Holtgrave, J Janet Kim, Chris Adkins, et al.
Annals of Neurology|September 30, 2021
Hydroxychloroquine for Primary Progressive Multiple SclerosisMarcus W Koch, Sharanjit Kaur, Kayla Sage, et al.
JAMA Network Open|June 15, 2021
Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer: A Secondary Post Hoc Analysis of the PREVAIL Randomized Clinical TrialAntonio Finelli, Tomasz M Beer, Simon Chowdhury, et al.
Research Square|July 18, 2023
Spatially resolved immune exhaustion within the alloreactive microenvironment predicts liver transplant rejectionArianna Barbetta, Brittany Rocque, Sarah Bangerth, et al.
Science Advances|April 12, 2024
Spatially resolved immune exhaustion within the alloreactive microenvironment predicts liver transplant rejectionArianna Barbetta, Brittany Rocque, Sarah Bangerth, et al.
JAMA Network Open|October 9, 2025
Barriers and Facilitators of Treatment Intensification in Metastatic Castration-Sensitive Prostate CancerStacy Loeb, Neeraj Agarwal, Nader El-Chaar, et al.
Drug and Alcohol Dependence|December 11, 2017
Cannabis use disorder and male sex predict medical cannabis card status in a sample of high risk adolescentsJanet Kim, Marilyn E Coors, Susan E Young, et al.
Prostate Cancer and Prostatic Diseases|July 24, 2025
Survival benefit associated with first-line androgen receptor pathway inhibitors for de novo metastatic castration-sensitive prostate cancerStephen J Freedland, Agnes Hong, Nader El-Chaar, et al.
Translational Andrology and Urology|March 14, 2022
ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD<sup>®</sup>) in Asian men with prostate cancerRohan Malek, Sheng-Tang Wu, Dennis Serrano, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
A novel RNA nucleic acid amplification test more accurately distinguishes active <i>Clostridioides difficile</i> infection from colonizationKenneth D Long, Daniel J Silberger, John Hernandez, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
AIDS and Behavior|July 30, 2013
Unmet HIV service needs among Black men who have sex with men in the United StatesDavid R Holtgrave, J Janet Kim, Chris Adkins, et al.
Annals of Neurology|September 30, 2021
Hydroxychloroquine for Primary Progressive Multiple SclerosisMarcus W Koch, Sharanjit Kaur, Kayla Sage, et al.
JAMA Network Open|June 15, 2021
Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer: A Secondary Post Hoc Analysis of the PREVAIL Randomized Clinical TrialAntonio Finelli, Tomasz M Beer, Simon Chowdhury, et al.
Research Square|July 18, 2023
Spatially resolved immune exhaustion within the alloreactive microenvironment predicts liver transplant rejectionArianna Barbetta, Brittany Rocque, Sarah Bangerth, et al.
Science Advances|April 12, 2024
Spatially resolved immune exhaustion within the alloreactive microenvironment predicts liver transplant rejectionArianna Barbetta, Brittany Rocque, Sarah Bangerth, et al.
JAMA Network Open|October 9, 2025
Barriers and Facilitators of Treatment Intensification in Metastatic Castration-Sensitive Prostate CancerStacy Loeb, Neeraj Agarwal, Nader El-Chaar, et al.
Drug and Alcohol Dependence|December 11, 2017
Cannabis use disorder and male sex predict medical cannabis card status in a sample of high risk adolescentsJanet Kim, Marilyn E Coors, Susan E Young, et al.
Prostate Cancer and Prostatic Diseases|July 24, 2025
Survival benefit associated with first-line androgen receptor pathway inhibitors for de novo metastatic castration-sensitive prostate cancerStephen J Freedland, Agnes Hong, Nader El-Chaar, et al.
Translational Andrology and Urology|March 14, 2022
ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD<sup>®</sup>) in Asian men with prostate cancerRohan Malek, Sheng-Tang Wu, Dennis Serrano, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
A novel RNA nucleic acid amplification test more accurately distinguishes active <i>Clostridioides difficile</i> infection from colonizationKenneth D Long, Daniel J Silberger, John Hernandez, et al.
Pageof 5